Cancer treatment often prompts patients and their families to explore supportive therapies that may improve outcomes, reduce treatment-related side effects, and enhance quality of life. Among these complementary approaches, intravenous (IV) vitamin C infusions have gained significant attention. Advocates suggest that high-dose vitamin C delivered directly into the bloodstream may help fight cancer, improve energy levels, reduce inflammation, and lessen the adverse effects of chemotherapy.
However, despite growing interest, vitamin C infusions remain a topic of ongoing scientific investigation. While some studies show promising results, experts emphasize that IV vitamin C should not replace standard cancer treatments.